May 4 (UPI) -- The Supreme Court on Monday blocked a lower court's ruling that implemented a nationwide ban on doctors prescribing the abortion drug mifepristone during telehealth visits.
The high court temporarily reinstated telehealth and mail access to the drug while it considers the case.
The 5th U.S. Circuit Court of Appeals on Friday unanimously ruled in favor of the state of Louisiana in its case asking for the ban.
One of the manufacturers of the drug, Danco, filed an appeal with the Supreme Court on Saturday asking for the ban to be lifted. The company said the appellate court's ruling leaves patients stuck in limbo because it didn't clarify the legal use of the drug.
About half of all abortions in the United States use medications such as mifepristone.
